Event Type
Disclosure
Mandatory
Variant
8-K
. Entry Into a Material Definitive Agreement. On January 8, 2026, iBio, Inc., a Delaware company (the “Company”), entered into a securities purchase agreement (
. Based in part upon the representations of the Investors in the Purchase Agreement, the offering and sale of the securities will be made in reliance on the exe
and in the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Exchan
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 4.1 Form of Pre-Funded Warrant 10.1 Form of Securities Purchase Agreement 10.2 Form of